Am. J. Respir. Crit. Care Med., Volume 163, Number 2, February 2001, 389-397

Deficiencies in Lung Surfactant Proteins A and D Are Associated with Lung Infection in Very Premature Neonatal Baboons

SHANJANA AWASTHI, JACQUELINE J. COALSON, BRADLEY A. YODER, ERIKA CROUCH, and RICHARD J. KING

Departments of Physiology, Pathology, and Pediatrics, University of Texas Health Science Center, and Southwest Foundation for Biomedical Research, San Antonio, Texas; and Department of Pathology, Washington University School of Medicine, St. Louis, Missouri

Surfactant proteins A (SP-A) and D (SP-D) are important in the innate host defense against pathogenic microorganisms. A deficit in these proteins in premature infants, either because of immaturity or as a consequence of superimposed chronic lung disease (CLD), could increase their susceptibility to infection. The study reported here examined infection in CLD in the premature newborn baboon, and correlated it with the amounts of SP-A and SP-D in lung tissue and lavage fluid. Two groups of baboons were delivered prematurely, at 125 d gestational age (g.a.), and differed principally in whether they developed naturally acquired pulmonary infections and sepsis. Group I animals were ventilated with clinically appropriate oxygen for 6 d and 14 d without clinical incident. Group II animals were ventilated for 5 to 71 d, but differed from those in Group I in that most developed pulmonary infection and/or sepsis. In Group I animals, tissue pools of both SP-A and SP-D were equal to or exceeded those in adults, and lavage pools of SP-A increased progressively with the time of ventilation to about 35% of adult levels after 14 d. In contrast, most Group II animals had concentrations of lavage SP-A that were less than 20% of that in adult animals. A low concentration of lavage SP-A correlated with the release of interleukin-8, and with a high "infection index" based on histopathology, microbiologic cultures, and clinical indications of sepsis. Our data suggest that the amounts of SP-A and SP-D in lavage fluid are indicators of the risk of infection in the evolution of neonatal CLD. Deficits in the amount of lavage SP-A, even after 60 d of ventilation, may have inhibited the resolution of infection and thereby contributed to the developing injury among our Group II animals.

This article has been cited by other articles:

				D. D. Sin, P. S. Pahlavan, and S.F. P. Man Review: Surfactant protein D: A lung specific biomarker in COPD? Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 65 - 74. [Abstract] [PDF]

				M. A. Thomson, B. A. Yoder, V. T. Winter, L. Giavedoni, L. Y. Chang, and J. J. Coalson Delayed Extubation to Nasal Continuous Positive Airway Pressure in the Immature Baboon Model of Bronchopulmonary Dysplasia: Lung Clinical and Pathological Findings Pediatrics, November 1, 2006; 118(5): 2038 - 2050. [Abstract] [Full Text] [PDF]

				J. W. Lee, B. Ovadia, A. Azakie, S. Salas, J. Goerke, J. R. Fineman, and J. A. Gutierrez Increased pulmonary blood flow does not alter surfactant protein gene expression in lambs within the first week of life Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1237 - L1243. [Abstract] [Full Text] [PDF]

				B. Grubor, J. M. Gallup, D. K. Meyerholz, E. C. Crouch, R. B. Evans, K. A. Brogden, H. D. Lehmkuhl, and M. R. Ackermann Enhanced Surfactant Protein and Defensin mRNA Levels and Reduced Viral Replication during Parainfluenza Virus Type 3 Pneumonia in Neonatal Lambs Clin. Vaccine Immunol., May 1, 2004; 11(3): 599 - 607. [Abstract] [Full Text] [PDF]

				W. Huang, G. Wang, D. S. Phelps, H. Al-Mondhiry, and J. Floros Human SP-A genetic variants and bleomycin-induced cytokine production by THP-1 cells: effect of ozone-induced SP-A oxidation Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L546 - L553. [Abstract] [Full Text] [PDF]

				J. K. van de Wetering, F. E. J. Coenjaerts, A. B. Vaandrager, L. M. G. van Golde, and J. J. Batenburg Aggregation of Cryptococcus neoformans by Surfactant Protein D Is Inhibited by Its Capsular Component Glucuronoxylomannan Infect. Immun., January 1, 2004; 72(1): 145 - 153. [Abstract] [Full Text] [PDF]

				Y.-Z. Wu, S. Medjane, S. Chabot, F. S. Kubrusly, I. Raw, M. Chignard, and L. Touqui Surfactant Protein-A and Phosphatidylglycerol Suppress Type IIA Phospholipase A2 Synthesis via Nuclear Factor-{kappa}B Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 692 - 699. [Abstract] [Full Text] [PDF]

				E. Koletsis, A. Chatzimichalis, V. Fotopoulos, K. Kokkinis, E. Papadimitriou, D. Tiniakos, E. Marinos, I. Bellenis, and D. Dougenis Donor Lung Pretreatment with Surfactant in Experimental Transplantation Preserves Graft Hemodynamics and Alveolar Morphology Experimental Biology and Medicine, May 1, 2003; 228(5): 540 - 545. [Abstract] [Full Text] [PDF]

				W. Huang, G. Wang, D. S. Phelps, H. Al-Mondhiry, and J. Floros Combined SP-A-bleomycin effect on cytokines by THP-1 cells: impact of surfactant lipids on this effect Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L94 - L102. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630. [Full Text] [PDF]

				T. R. Korfhagen Surfactant Protein A (SP-A)-Mediated Bacterial Clearance . SP-A and Cystic Fibrosis Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 668 - 672. [Full Text] [PDF]